Pew Applauds U.S. House Passage of FDA User Fee Legislation
WASHINGTON—The U.S. House of Representatives Wednesday passed the Food and Drug Administration Safety and Innovation Act (S. 3187), a bill to support the FDA's drug and device reviews.
"We commend the House for passing the bipartisan Food and Drug Administration Safety and Innovation Act," said Allan Coukell, director of medical programs at the Pew Health Group. "This legislation will help deliver safe, effective and innovative medical products to patients. We also commend the Energy and Commerce Committee for its leadership throughout this process. We look forward to the bill's passage through the U.S. Senate."